These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 169722)
21. Effects of prostaglandin E2, indomethacin, trifluoperazine and drugs affecting the cytoskeleton on collagenase production by cultured adherent rheumatoid synovial cells. Dayer JM; Roelke MS; Krane SM Biochem Pharmacol; 1984 Sep; 33(18):2893-9. PubMed ID: 6089839 [TBL] [Abstract][Full Text] [Related]
22. Evidence for multiple bone resorption-stimulating factors produced by normal human keratinocytes in culture. Fried RM; Voelkel EF; Rice RH; Levine L; Tashjian AH Endocrinology; 1988 Jun; 122(6):2467-75. PubMed ID: 2453341 [TBL] [Abstract][Full Text] [Related]
23. Role of local prostaglandin synthesis in the modulation of proliferative activity of rat colonic epithelium. Craven PA; Saito R; DeRubertis FR J Clin Invest; 1983 Oct; 72(4):1365-75. PubMed ID: 6313761 [TBL] [Abstract][Full Text] [Related]
24. Production of collagenase and inhibitor (TIMP) by normal, rheumatoid and osteoarthritic synovium in vitro: effects of hydrocortisone and indomethacin. McGuire MB; Murphy G; Reynolds JJ; Russell RG Clin Sci (Lond); 1981 Dec; 61(6):703-10. PubMed ID: 6271449 [TBL] [Abstract][Full Text] [Related]
25. Corticosteroids inhibit prostaglandin production by rheumatiod synovia. Kantrowitz F; Robinson DR; McGuire MB; Levine L Nature; 1975 Dec; 258(5537):737-9. PubMed ID: 1207758 [No Abstract] [Full Text] [Related]
26. Differential effects of prostaglandin synthetase inhibitors on prostaglandin E2 binding and on prostaglandin- or cholera toxin-induced cyclic AMP accumulation in the rabbit uterus. Zor U; Koch R; Naor Z Adv Prostaglandin Thromboxane Res; 1976; 1():331-5. PubMed ID: 187046 [TBL] [Abstract][Full Text] [Related]
27. Secretion of prostaglandins as bone-resorbing agents by renal cortical carcinoma in culture. Atkins D; Ibbotson KJ; Hillier K; Hunt NH; Hammonds JC; Martin TJ Br J Cancer; 1977 Nov; 36(5):601-7. PubMed ID: 201261 [TBL] [Abstract][Full Text] [Related]
28. [Prostaglandin and leukotriene release of synovial tissue in various joint diseases]. Wittenberg RH; Willburger RE; Kleemeyer KS; Schleberger R Z Orthop Ihre Grenzgeb; 1991; 129(6):531-6. PubMed ID: 1837403 [TBL] [Abstract][Full Text] [Related]
29. Cell-cell interactions in the rheumatoid joint. McGuire MK; Meats JE; Russell RG Agents Actions; 1980 Dec; 10(6):486-90. PubMed ID: 7270332 [TBL] [Abstract][Full Text] [Related]
30. Prostaglandin production in arthritis. Sturge RA; Yates DB; Gordon D; Franco M; Paul W; Bray A; Morley J Ann Rheum Dis; 1978 Aug; 37(4):315-20. PubMed ID: 686864 [TBL] [Abstract][Full Text] [Related]
31. Messenger function of prostaglandins in cell to cell interactions and control of proteinase activity in the rheumatoid joint. McGuire MK; Meats JE; Ebsworth NM; Murphy G; Reynolds JJ; Russell RG Int J Immunopharmacol; 1982; 4(2):91-102. PubMed ID: 6284664 [TBL] [Abstract][Full Text] [Related]
32. [Mononucleated phagocytes from rheumatoid synovial fluid. Synthesis of prostanoids and first pharmacological applications]. Poubelle P; Chaintreuil J; Blotman F; Damon M; Flandre O; Crastes de Paulet A; Simon L Rev Rhum Mal Osteoartic; 1982 Jun; 49(7):525-31. PubMed ID: 7123126 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical localization of prostaglandin E in rheumatoid synovial tissues. Husby G; Bankhurst AD; Williams RC Arthritis Rheum; 1977 Apr; 20(3):785-91. PubMed ID: 324481 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the effects of different anti-inflammatory drugs on synovial fluid prostanoid concentrations in patients with rheumatoid arthritis. Seppälä E; Nissilä M; Isomäki H; Nuotio P; Nykänen E; Laitinen O; Vapaatalo H Clin Rheumatol; 1985 Sep; 4(3):315-20. PubMed ID: 3864577 [TBL] [Abstract][Full Text] [Related]
35. Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer. Tashjian AH; Voelkel EF; Levine L; Goldhaber P J Exp Med; 1972 Dec; 136(6):1329-43. PubMed ID: 4345106 [TBL] [Abstract][Full Text] [Related]
36. Palytoxin: an extraordinarily potent stimulator of prostaglandin production and bone resorption in cultured mouse calvariae. Lazzaro M; Tashjian AH; Fujiki H; Levine L Endocrinology; 1987 Apr; 120(4):1338-45. PubMed ID: 2435535 [TBL] [Abstract][Full Text] [Related]
37. Fibronectin in plasma and synovial fluid of patients with rheumatic diseases. Duţu A; Vlaicu-Rus V; Boloşiu HD; Parasca I; Cristea A Med Interne; 1986; 24(1):61-8. PubMed ID: 3518030 [TBL] [Abstract][Full Text] [Related]
38. The stimulation of human synovial fibroblast plasminogen activator activity. Involvement of cyclic AMP and cyclooxygenase products. Hamilton JA; Leizer T; Lingelbach SR Biochim Biophys Acta; 1986 Apr; 886(2):195-202. PubMed ID: 2421780 [TBL] [Abstract][Full Text] [Related]
39. Platelet-derived growth factor stimulates bone resorption via a prostaglandin-mediated mechanism. Tashjian AH; Hohmann EL; Antoniades HN; Levine L Endocrinology; 1982 Jul; 111(1):118-24. PubMed ID: 6177524 [TBL] [Abstract][Full Text] [Related]
40. Endogenous prostaglandin E2 inhibits aberrant overgrowth of rheumatoid synovial tissue and the development of osteoclast activity through EP4 receptor. Shibata-Nozaki T; Ito H; Mitomi H; Akaogi J; Komagata T; Kanaji T; Maruyama T; Mori T; Nomoto S; Ozaki S; Yamada H Arthritis Rheum; 2011 Sep; 63(9):2595-605. PubMed ID: 21898865 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]